Zacks Investment Research on MSN
Vertex Pharmaceuticals (VRTX) Stock Moves -1.23%: What You Should Know
In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $417.21, marking a -1.23% move from the previous day. Elsewhere, the Dow saw a downswing of 0.16%, while the tech-heavy Nasdaq ...
Zacks Investment Research on MSN
Exploring Analyst Estimates for Vertex (VRTX) Q3 Earnings, Beyond Revenue and EPS
In its upcoming report, Vertex Pharmaceuticals (VRTX) is predicted by Wall Street analysts to post quarterly earnings of $4.55 per share, reflecting an increase of 3.9% compared to the same period ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results